Osteosarcoma — Trials

Osteosarcoma — Trials · CancerIndex

Clinical trials

Registered studies

349 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 99
Recruiting: 58
Ph III recruiting: 2
Growth YoY: —
Industry share: 14%
Top sponsor: National Cancer Institute (NCI)
Termination share: 33.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (40)

clinicaltrialsPublishedShowing 51–54 of 54 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06114225	Pulmonary Resectable Osteosarcoma Treated by Metastasectomy and Pre-operative Immunotherapy and Stereotactic Body Radiotherapy (PROMIS): a Prospective Clinical Trial(PROMIS)	recruiting	Phase 2	43	Ruijin HospitalOTHER	1	Nov 2, 2023	clinicaltrials
NCT06041490	Adjuvant Therapy for High-risk Hepatocellular Carcinoma Post Liver Transplantation	not yet recruiting	Phase 2	88	Peking Union Medical College HospitalOTHER	1	Sep 18, 2023